WASHINGTON, April 4 -- The Congressional Research Service issued the following report (No. R47495) on April 3, 2023, entitled "Regional Innovation: Federal Programs and Issues for Consideration:" (Continued from Part 2 of 3) * * * Considerations for Congress The growth in federal attention to and support for regional innovation, including the establishment of several new RIS programs in the CHIPS and Science Act (P.L. 117-167), raises a number of implementation and execution issues for Congr  more

WASHINGTON, April 5 -- Rep. Sharice Davids, D-Kansas, issued the following news release on April 4, 2023: After learning of unresolved pandemic-related small business fraud cases in Kansas' Third District, Representative Sharice Davids questioned Small Business Administration (SBA) Administrator Isabella Casillas Guzman during a House Small Business Committee hearing on the SBA's efforts to investigate these cases and support victims. Davids mentioned Kansans who have been targeted by bad actor  more

WASHINGTON, April 5 -- The Senate Judiciary Committee issued the following written testimony by Eric Ruben, a professor at the Southern Methodist University Dedman School of Law, involving a hearing on March 15, 2023, entitled "Protecting Public Safety After New York State Rifle and Pistol Association vs. Bruen": * * * Thank you for inviting me to testify regarding the state of Second Amendment case law after the Supreme Court's landmark decision in New York State Rifle and Pistol Association   more

WASHINGTON, April 5 -- Sen. Roger Marshall, R-Kansas, issued the following news release: U.S. Senators Roger Marshall, M.D. and Peter Welch (D-VT) have introduced the Drug Price Transparency in Medicaid Act of 2023, legislation to limit abusive pricing practices by pharmacy benefit managers (PBMs), including the use of a technique called 'spread pricing,' where PBMs charge Medicaid more than they pay pharmacies for a particular drug. In so doing, PBMs increase their profits while driving up cos  more

WASHINGTON, April 5 -- Sen. Peter Welch, D-Vermont, issued the following news release: Senator Peter Welch (D-VT) and Senator Roger Marshall (R-KS) announced the introduction of the Drug Price Transparency in Medicaid Act of 2023, legislation to limit abusive pricing practices by pharmacy benefit managers (PBMs), including the use of a technique called 'spread pricing,' where PBMs charge Medicaid more than they pay pharmacies for a particular drug. In so doing, PBMs increase their profits, whil  more